Maxxon, Inc.

Safety syringe sample batch to be produced; patent filed for plunger technology

Published in Drug Law Weekly, November 8th, 2005

Maxxon, Inc. (MXON) announced that its Maxxon/Globe Joint Venture (JV) has ordered a 5,000 piece sample batch of its functional 3cc ReVac Safety Syringe.

The 5,000 piece lot will be manufactured with U.S. Food and Drug Administration (FDA) certified medical grade materials. The specified materials have already been ordered and are scheduled for delivery to the manufacturing facility.

The sample set is designed to meet FDA criteria and is scheduled for completion within 2-3 weeks. The sample lot shall be used for U.S. FDA application, as well as distributor's evaluation.

In addition, the JV intends to send samples to the European...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2005-11-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry